Literature DB >> 4999216

Effects of ethionamide and isoxyl on mycolic acid synthesis in Mycobacterium tuberculosis BCG.

F G Winder, P B Collins, D Whelan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4999216     DOI： 10.1099/00221287-66-3-379

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN： 0022-1287


× No keyword cloud information.
  24 in total

1.  Antimycobacterial activities of isoxyl and new derivatives through the inhibition of mycolic acid synthesis.

Authors:  B Phetsuksiri; A R Baulard; A M Cooper; D E Minnikin; J D Douglas; G S Besra; P J Brennan
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Galactosyl transferases in mycobacterial cell wall synthesis.

Authors:  Martina Belánová; Petronela Dianisková; Patrick J Brennan; Gladys C Completo; Natisha L Rose; Todd L Lowary; Katarína Mikusová
Journal:  J Bacteriol       Date:  2007-11-30       Impact factor: 3.490

Review 3.  Tuberculosis pharmacotherapy: strategies to optimize patient care.

Authors:  Carole D Mitnick; Bryan McGee; Charles A Peloquin
Journal:  Expert Opin Pharmacother       Date:  2009-02       Impact factor: 3.889

4.  Lack of Specificity of Phenotypic Screens for Inhibitors of the Mycobacterium tuberculosis FAS-II System.

Authors:  Anna E Grzegorzewicz; Joël Lelièvre; Jorge Esquivias; Bhanupriya Angala; Jiuyu Liu; Richard E Lee; Michael R McNeil; Mary Jackson
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

5.  Inhibition by ethambutol of mycolic acid transfer into the cell wall of Mycobacterium smegmatis.

Authors:  K Takayama; E L Armstrong; K A Kunugi; J O Kilburn
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

6.  Activity of subinhibitory concentrations of dapsone alone and in combination with cell-wall inhibitors against Mycobacterium avium complex organisms.

Authors:  N Rastogi; K S Goh; V Labrousse
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-12       Impact factor: 3.267

7.  Unique mechanism of action of the thiourea drug isoxyl on Mycobacterium tuberculosis.

Authors:  Benjawan Phetsuksiri; Mary Jackson; Hataichanok Scherman; Michael McNeil; Gurdyal S Besra; Alain R Baulard; Richard A Slayden; Andrea E DeBarber; Clifton E Barry; Mark S Baird; Dean C Crick; Patrick J Brennan
Journal:  J Biol Chem       Date:  2003-10-14       Impact factor: 5.157

8.  Inhibition of the incorporation of 14C-precursors in Mycobacterium smegmatis by antibiotics and chemotherapeutics.

Authors:  V Majtán
Journal:  Folia Microbiol (Praha)       Date:  1982       Impact factor: 2.099

9.  A common mechanism of inhibition of the Mycobacterium tuberculosis mycolic acid biosynthetic pathway by isoxyl and thiacetazone.

Authors:  Anna E Grzegorzewicz; Jana Korduláková; Victoria Jones; Sarah E M Born; Juan M Belardinelli; Adrien Vaquié; Vijay A K B Gundi; Jan Madacki; Nawel Slama; Françoise Laval; Julien Vaubourgeix; Rebecca M Crew; Brigitte Gicquel; Mamadou Daffé; Hector R Morbidoni; Patrick J Brennan; Annaik Quémard; Michael R McNeil; Mary Jackson
Journal:  J Biol Chem       Date:  2012-09-21       Impact factor: 5.157

10.  Transposon-5 mutagenesis transforms Corynebacterium matruchotii to synthesize novel hybrid fatty acids that functionally replace corynomycolic acid.

Authors:  Kuni Takayama; Barry Hayes; Matha M Vestling; Randall J Massey
Journal:  Biochem J       Date:  2003-07-15       Impact factor: 3.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.